HAB Pharma names Pankaj Agarwal as Chief Financial Officer

0
60
HAB Pharma strengthens finance leadership with Pankaj Agarwal’s appointment
HAB Pharma strengthens finance leadership with Pankaj Agarwal’s appointment

HAB Pharma has strengthened its senior finance leadership with the appointment of Pankaj Agarwal as Chief Financial Officer. With nearly 18 years of experience across healthcare and pharmaceuticals, Agarwal will oversee financial planning, budgeting, reporting, compliance, risk management and corporate governance.

Before joining HAB Pharma, Agarwal held senior finance positions at Innovcare Lifesciences, Max Healthcare and Vyome Biosciences.

At Innovcare Lifesciences, he was involved in a USD 5 million Series C fundraise and an additional USD 1 million raised through non-convertible debentures. He also led the implementation of SAP for the accounts function.

Agarwal started his career in audit and compliance with PricewaterhouseCoopers and later worked as a partner at Lahoti Roy & Associates.

At HAB Pharma, his responsibilities will include financial planning, budgeting, reporting, compliance, risk management and governance. He will also work with the leadership team on business planning, operational efficiency and financial decisions as the company expands its manufacturing and research activities.

Agarwal is a Chartered Accountant and has completed a Post Graduate Executive Management Programme in Finance and Sales from SPJIMR, Mumbai.

Commenting on the appointment, Saurabh Agarwal, CEO and Director, HAB Pharma, said, “Since joining HAB Pharma in February, Pankaj has brought a strong focus on financial discipline, structured planning and informed decision-making.”

He added that Agarwal’s understanding of finance, compliance and business operations would help strengthen the company’s financial and governance framework.

Pankaj Agarwal, Chief Financial Officer, HAB Pharma, said, “The organisation is at an important stage of its evolution, with significant opportunities across manufacturing, R&D, exports and domestic markets.”

He added that his focus would remain on strengthening financial processes and improving operational efficiency.

The appointment comes as HAB Pharma works to expand its manufacturing footprint, product pipeline and presence across domestic and international markets. Agarwal’s role will focus on supporting these plans through financial controls, planning and governance.

Also read: Viksit Workforce for a Viksit Bharat

Do Follow: The Mainstream LinkedIn | The Mainstream Facebook | The Mainstream Youtube | The Mainstream Twitter

About us:

The Mainstream is a premier platform delivering the latest updates and informed perspectives across the technology business and cyber landscape. Built on research-driven, thought leadership and original intellectual property, The Mainstream also curates summits & conferences that convene decision makers to explore how technology reshapes industries and leadership. With a growing presence in India and globally across the Middle East, Africa, ASEAN, the USA, the UK and Australia, The Mainstream carries a vision to bring the latest happenings and insights to 8.2 billion people and to place technology at the centre of conversation for leaders navigating the future.